PortfoliosLab logoPortfoliosLab logo
ALT vs. BLNK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ALT vs. BLNK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Altimmune, Inc. (ALT) and Blink Charging Co. (BLNK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ALT achieves a -18.84% return, which is significantly lower than BLNK's -2.16% return.


ALT

1D
8.52%
1M
1.03%
YTD
-18.84%
6M
-29.23%
1Y
-58.32%
3Y*
-9.17%
5Y*
-28.96%
10Y*
-28.57%

BLNK

1D
0.40%
1M
-20.43%
YTD
-2.16%
6M
-12.99%
1Y
-29.90%
3Y*
-51.33%
5Y*
-56.07%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ALT vs. BLNK - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ALT
Altimmune, Inc.
-18.84%-49.93%-35.91%-31.61%79.59%-18.79%496.83%-8.25%-95.42%
BLNK
Blink Charging Co.
-2.16%-52.01%-59.00%-69.10%-58.62%-37.99%2,198.39%8.14%-80.61%

Correlation

The correlation between ALT and BLNK is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.34

Correlation (3Y)
Calculated over the trailing 3-year period

0.34

Correlation (5Y)
Calculated over the trailing 5-year period

0.36

Correlation (All Time)
Calculated using the full available price history since Feb 13, 2018

0.27

Fundamentals

Market Cap

ALT:

$364.67M

BLNK:

$93.43M

EPS

ALT:

-$0.92

BLNK:

-$0.63

PS Ratio

ALT:

8.06K

BLNK:

0.74

PB Ratio

ALT:

1.28

BLNK:

1.73

Total Revenue (TTM)

ALT:

$36.00K

BLNK:

$103.40M

Gross Profit (TTM)

ALT:

-$14.92M

BLNK:

$24.62M

EBITDA (TTM)

ALT:

-$93.48M

BLNK:

-$58.57M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ALT vs. BLNK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALT
ALT Risk / Return Rank: 1515
Overall Rank
ALT Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
ALT Sortino Ratio Rank: 2020
Sortino Ratio Rank
ALT Omega Ratio Rank: 1717
Omega Ratio Rank
ALT Calmar Ratio Rank: 88
Calmar Ratio Rank
ALT Martin Ratio Rank: 1616
Martin Ratio Rank

BLNK
BLNK Risk / Return Rank: 3232
Overall Rank
BLNK Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
BLNK Sortino Ratio Rank: 3535
Sortino Ratio Rank
BLNK Omega Ratio Rank: 3434
Omega Ratio Rank
BLNK Calmar Ratio Rank: 2929
Calmar Ratio Rank
BLNK Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALT vs. BLNK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Altimmune, Inc. (ALT) and Blink Charging Co. (BLNK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ALTBLNKDifference
Sharpe ratioReturn per unit of total volatility

-0.33

Sortino ratioReturn per unit of downside risk

-0.67

Omega ratioGain probability vs. loss probability

0.91

1.02

-0.10

Calmar ratioReturn relative to maximum drawdown

-0.88

-0.38

-0.51

Martin ratioReturn relative to average drawdown

-1.16

-0.55

-0.61

ALT vs. BLNK - Sharpe Ratio Comparison

The current ALT Sharpe Ratio is -0.65, which is lower than the BLNK Sharpe Ratio of -0.31. The chart below compares the historical Sharpe Ratios of ALT and BLNK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ALT vs. BLNK - Drawdown Comparison

The maximum ALT drawdown since its inception was -99.63%, roughly equal to the maximum BLNK drawdown of -99.17%. Use the drawdown chart below to compare losses from any high point for ALT and BLNK.


Loading charts...

Drawdown Indicators


ALTBLNKDifference

Max Drawdown

Largest peak-to-trough decline

-99.63%

-99.17%

-0.46%

Max Drawdown (1Y)

Largest decline over 1 year

-66.41%

-79.94%

+13.53%

Max Drawdown (3Y)

Largest decline over 3 years

-81.25%

-92.69%

+11.44%

Max Drawdown (5Y)

Largest decline over 5 years

-90.45%

-98.93%

+8.48%

Max Drawdown (10Y)

Largest decline over 10 years

-99.63%

Current Drawdown

Current decline from peak

-99.29%

-98.93%

-0.36%

Average Drawdown

Average peak-to-trough decline

-78.91%

-73.53%

-5.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

50.09%

54.36%

-4.27%

Volatility

ALT vs. BLNK - Volatility Comparison

The current volatility for Altimmune, Inc. (ALT) is 14.12%, while Blink Charging Co. (BLNK) has a volatility of 16.29%. This indicates that ALT experiences smaller price fluctuations and is considered to be less risky than BLNK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ALTBLNKDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.12%

16.29%

-2.17%

Volatility (6M)

Calculated over the trailing 6-month period

60.60%

63.22%

-2.62%

Volatility (1Y)

Calculated over the trailing 1-year period

90.63%

96.32%

-5.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

94.20%

83.12%

+11.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

149.74%

121.19%

+28.55%

Dividends

ALT vs. BLNK - Dividend Comparison

Neither ALT nor BLNK has paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
ALT
Altimmune, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1,462.31%
BLNK
Blink Charging Co.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ALT vs. BLNK - Financials Comparison

This section allows you to compare key financial metrics between Altimmune, Inc. and Blink Charging Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M202220232024202520260
20.78M
(ALT) Total Revenue
(BLNK) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ALT and BLNK have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BLNK has higher volatility (16.29%) compared to ALT (14.12%). In terms of maximum drawdown, ALT dropped -99.63% vs BLNK's -99.17%.

BLNK currently has the higher Sharpe Ratio (-0.31 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ALT and BLNK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer